Sangeetha Prakash

Sangeetha Prakash is a seasoned Regulatory CMC professional with extensive experience in cell therapy and complex biological products. Currently, she holds the position of Director at Takeda in Cambridge, MA, where she leads global regulatory strategies for a commercial cell therapy product and various early-stage portfolio products. Her expertise includes developing submission strategies, managing health authority interactions, and leading teams to ensure product supply and compliance. Before her current role, she was a Senior Manager at Bristol Myers Squibb where she supported the commercial filing of a cell therapy product in global markets. Her career also includes positions at Merck and Teva Pharmaceuticals, where she refined her expertise in regulatory affairs and CMC. Her educational background includes an M.S. in Molecular and Cell Biology with a specialty in Immunology from the University of Pierre-Marie Curie in Paris, France.